title: Urinary zinc loss in sickle cell disease primarily due to increased bone degradation.
authors.affiliation: Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Schimmel
authors.affiliation: Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: E
authors.initials: E
authors.lastname: Nur
authors.affiliation: Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands.
authors.forename: W
authors.initials: W
authors.lastname: Mairuhu
authors.affiliation: Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands.
authors.forename: D P M
authors.initials: DP
authors.lastname: Brandjes
authors.affiliation: Department of Nephrology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: R H G
authors.initials: RH
authors.lastname: Olde Engberink
authors.affiliation: Department of Nephrology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: L
authors.initials: L
authors.lastname: Vogt
authors.affiliation: Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: B J
authors.initials: BJ
authors.lastname: Biemond
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000378:metabolism / Q000473:pathology / Q000652:urine*; D001862:Bone Resorption / Q000378:metabolism / Q000473:pathology / Q000652:urine*; D001842:Bone and Bones / Q000378:metabolism / Q000473:pathology; D015331:Cohort Studies; D006801:Humans; D008297:Male; D055815:Young Adult; D015032:Zinc / Q000172:deficiency* / Q000652:urine*
chemical_list: D015032:Zinc